At a glance
ClinicalIndex Comparison RecordN/ACompleted· 369 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Live Lung Donor Retrospective Study (RELIVE-02)
National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Nov 5, 2007·Updated Mar 27, 2017
In Brief
An observational study for Lung Transplantation. Completed, enrolled 369 participants across 2 sites.
Detailed Summary
The use of live donors for solid organ transplantation has increased the number of available organs for those waiting for a transplant. Donation of an organ may have significant effects on a donor's health. This study will determine the baseline characteristics, early postoperative morbidity, and long-term survival for participants who underwent donor lobectomy between 1993 and 2006.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Transplantation
CountriesUnited States
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2007
First PostedNov 2007
Primary CompletionDec 2008
TodayJul 2026
First PostedNov 5, 2007
Enrollment StartOct 1, 2007
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 18.7 years ago